inpellis is Pharmaceuticals in United States that focus on peripheral neuropathy business. Founded in 2012. They cover business area such as operator, trans-dermal product candidate, acute and chronic pain, trans-dermal drug, novel technological advance, musculoskeletal disorder, biophysical modulation, medical researcher, an alternative, FDA-approve drug.
2012
( 12 years old in 2024 )
Peripheral Neuropathy
-
30 Washington Avenue
Suite F
Haddonfield, NJ 08033
United States
Private
operatortrans-dermal product candidateacute and chronic paintrans-dermal drugnovel technological advancemusculoskeletal disorderbiophysical modulationmedical researcheran alternativeFDA-approve drug
* We use standard office opening hours in near inpellis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Inpellis is Pharmaceuticals business from United States that founded in 2012 (12 years old in 2024), inpellis business is focusing on Peripheral Neuropathy.
inpellis headquarter office and corporate office address is located in 30 Washington Avenue Suite F Haddonfield, NJ 08033 United States.
inpellis was founded in United States.
In 2024, inpellis is currently focus on peripheral neuropathy sector.
Above is snippet of Google Trends for "peripheral neuropathy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with inpellis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
